Keywords: polpharma, forecasts, 213m, revenues, polish, drugmaker, forecasting
Polpharma forecasts $213M revenues
Article | 20 October 2003
Polish drugmaker Polpharma is forecasting revenues of 815 million zlotys ($213 million) for 2003, according to the Interfax news agency, an increase of 6% ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
